A prospective double-blind study compared the analgesic effectiveness of peribulbar lignocaine with peribulbar morphine and lignocaine for postoperative analgesia in pterygium surgery. Twenty patients were randomly divided to receive a peribulbar injection preoperatively of either 1% lignocaine 2 ml or 1% lignocaine 1.6 ml and 4 mg morphine. Effects on pain at injection and pain at 24 hours and 48 hours postoperatively were measured with a visual analog pain scale. Effects of the injections on sedation, pupil size and unwanted side-effects were also recorded. The groups were comparable for age, weight and surgical technique. There was a significantly lower pain score at 24 hours after operation in the morphine group (P=0.035). There were no significant differences in sedation or side-effects between the groups. The physiological effects of morphine on the eye are reviewed. The study suggests that orbital morphine may be an effective and safe form of analgesia for corneal surgery and further investigation is warranted.
In our unit, a survey revealed that 60% of patients undergoing pterygium excision and 8% of patients undergoing Lasik refractive surgery experienced pain scores greater than 3/10 in the 24 hours following surgery.
Chronic use of local anaesthetic agents is known to cause an increased incidence of infection and scarring of a disrupted cornea, while the effect of peribulbar or retrobulbar injection of local anaesthetic agents only lasts a few hours. The slow onset of topical ketorolac and diclofenac limits their effectiveness in acute pain relief 1 .
Our study was designed to quantify the spectrum of pain experienced by pterygium patients to determine whether the injection of peribulbar morphine had any effect on postoperative pain and what other sideeffects resulted from such treatment.
MATERIALS AND METHOD
After approval was obtained from the Hospital Centre Ethics Committee, 20 patients aged 18 to 73 years scheduled for pterygium excision were entered into a double-blind prospective randomized trial comparing peribulbar lignocaine to peribulbar morphine and lignocaine. Consent was obtained from the patients. All patients were day case patients and ASA class 1 or 2.
Patients were randomly allocated to receive either lignocaine 1% 2 ml or lignocaine 1% 1.6 ml plus morphine 4 mg in 0.4 ml. The solutions were prepared in identical syringes. The anaesthetist and the surgeon were unaware of the contents of the syringe.
Patients received a bolus of 1 mg of midazolam and 20 mg of propofol. (Time 0). At T+30 seconds all patients received two drops of benoxinate topical anaesthetic (BNX). At T+90 seconds all patients received test solutions by peribulbar injection: 1 ml was injected into the infero-temporal region of the orbit at a depth of 20 millimetres and 1 ml in the medial orbit at a depth of 20 millimetres. Pupil sizes were measured prior to sedation and prior to surgery. The pain of the injection was assessed by the patient at T+8 minutes by marking their level of pain on 0 to 10 visual analog pain scale. Four drops of benoxinate were applied to the eye after the insertion of a lid retractor and lignocaine 1% plus adrenaline was injected into the pterygium by the surgeon. All surgery was identical, being excision and rotation flap graft.
Postoperatively all patients were given written instructions for analgesia consisting of paracetamol 1 g every 4 hours if awake, for 24 hours postoperatively as required. The patient was also given the option to take oral paracetamol plus codeine 16 mg if the paracetamol alone was inadequate. These instructions were given in written form and the decision to use the paracetamol and codeine was left to the discretion of the patient. In recovery patients were asked for their comfort status and any reply of nausea, vomiting or itching was noted. The conscious level of the patient was assessed in recovery by the anaesthetist.
Twenty-four hours postoperatively, patients were all reviewed by the surgeon. In addition to surgical review, patients were asked whether they required paracetamol plus codeine and whether they were comfortable, again noting any history of sedation, nausea or itching. Intraocular pressures were measured at this stage. During this review the patient completed a second pain score.
At 48 hours postoperatively the patient completed a third pain score at home, which was mailed back to the investigators.
The pain scale scores were analysed using Student's two-tailed t test.
RESULTS
The two groups were comparable with respect to age, surgical technique and time from injection to surgery. There was no difference in pain scores for the injections. At 24 hours post surgery there was a significant difference (P=0.035) in pain scores, with the morphine and lignocaine group mean of 1.63 (range 0 to 4.5) and the lignocaine group 3.86 (range 0.2 to 9.6) (P=0.035).
At 48 hours the difference between the two groups did not reach significance (P=0.21). For the morphine and lignocaine group the mean was 0.83 (range 0 to 4.5), and the lignocaine group 1.63 (0 to 4.2).
Two patients in the lignocaine group complained of severe pain in the first 24 hours and used one dose of paracetamol 1.5 g and codeine 24 mg for analgesia. None of the patients in the morphine group complained of severe postoperative pain or used paracetamol and codeine for analgesia.
Pupil Size
In the lignocaine group the pupil of the operated eye dilated in nine of the 10 patients, the other remaining unchanged. On the contralateral side the pupil remained unchanged in seven, dilated in two and constricted in one patient.
In the morphine group the pupil of the operated eye remained unchanged in four patients, dilated in four patients and constricted in two patients. On the contralateral side the pupil remained unchanged in five patients and constricted in five patients.
One of the lignocaine group and two of the morphine group were given metoclopromide for postoperative nausea. One of the morphine group patients vomited once postoperatively. In both groups one patient complained of itching postoperatively.
One patient in the lignocaine group had an abnormal intraocular pressure at 24 hours postoperatively which settled prior to the next review. All patients remained alert and cooperative throughout surgery and in the recovery ward.
DISCUSSION
While the use of opium in the eye was recorded over 500 years ago 2 , there is no reference to its use in modern medical literature. In 1994 Peyman et al 3 reported the use of morphine eye drops in two parallel studies. The first study investigated the effects of morphine and lignocaine in denuded corneal healing of rabbits. The second study assessed the irritation threshold in humans with corneal abrasions.
They demonstrated conclusively that two drops of morphine (0.5 mg/ml) was effective as an analgesic in the damaged but not intact cornea, and unlike proxymetacaine hydrochloride, a local anaesthetic agent, it did not interfere with corneal wound healing. In 1996 Boezart et al 4 reported the use of retrobulbar morphine in the anaesthesia of 10 patients with severe intractable eye pain.
In this report they demonstrated a dramatic reduction in pain from an average visual analog pain score of 8.8+1.03 to 0.3+0.48 at 48 hours post injection of 1 mg of morphine into the retrobulbar space and 3 mg morphine into the peribulbar space.
There is growing evidence of the peripheral effects of opioid analgesics, in contradiction to the traditional beliefs that opioids exerted their analgesic effects purely by central mechanisms 5 . The precise location of the receptors that are mediating the analgesic effect we have demonstrated is unknown. Nor is it known why topical morphine does not have analgesic effects on the intact cornea. Two possible explanations are that opioids have easier access to receptors in the presence of inflammation 6 and that opioid receptors are transported down the axons to the inflamed site 7 .
The role of morphine and endogenous opioids on the pupil is also now more complex than once believed. Miosis is primarily controlled by the Edinger-Westphal nucleus of the oculomotor nerve at the base of the fourth ventricle. Morphine may act by inhibition of catecholaminergic fibres, which normally control pre-ganglionic sympathetic neurones in the central nervous system 8 .
Topical morphine causes miosis only in the eye into which it is instilled 8 . This can be reversed with topical naloxone 8 . By itself naloxone is not a mydriatic 8 . Furthermore topical morphine can reduce a homatropine-induced mydriasis 8 .
Together these facts point to topical morphine acting by stimulation of opiate receptors located on the noradrenergic endings in the neuromuscular junction of the iris 7 . In our study, the miosis noted in the morphine injected orbits was inconsistent and mild. No patients developed "pinpoint" pupils. There was a slight (but not statistically significant) miosis on the contralateral pupil in the patients receiving morphine, which maybe due to a systemic effect of the morphine. Should further studies demonstrate the efficacy of peribulbar morphine, it may be preferable to the topical or systemic route for eye analgesia where miosis is undesirable.
While the incidence of side-effects was low, we do not believe any conclusion can be drawn on the likely incidence of side-effects for peribulbar injections due to the small sample size.
Of interest, one patient had bilateral pterygium surgery and as the selection would have it, received morphine on the first occasion but not on the second. Pain scores were 2.9, 1.7, 0.3, for the 5 minute, 24 hour and 48 hour scores after receiving morphine 2.0, 3.0, 2.6 for the corresponding surgery without morphine. While not asserting this as anything more than interesting, the possibility of conducting such a crossover technique trial in the future is worthy of mention.
It is our intention to commence trials with morphine eye drops. The complexity of the formulation of such eye drops necessitated this peribulbar study to establish the likelihood of effectiveness and incidence of side-effects of orbital morphine before embarking on a complex chemical formulation.
The small dose of topical morphine required by Peyman in his study suggests that morphine drops may be an effective and safe mode of analgesia.
Our study suggests that peribulbar morphine is an effective analgesic modality for 24 hours postoperatively in pterygium surgery and is not accompanied by serious side-effects. Although we acknowledge the small size of our trial, our results support the conclusions of Peyman and Boezart and we believe that further clinical research into the use of peribulbar and topical morphine for eye analgesia should continue.
